nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Methotrexate—bone cancer	0.464	1	CbGbCtD
Penicillamine—Extravasation—Carboplatin—bone cancer	0.0234	0.0437	CcSEcCtD
Penicillamine—Guillain-Barre syndrome—Methotrexate—bone cancer	0.0226	0.0423	CcSEcCtD
Penicillamine—Alveolitis allergic—Methotrexate—bone cancer	0.0126	0.0235	CcSEcCtD
Penicillamine—Leukaemia—Methotrexate—bone cancer	0.0122	0.0228	CcSEcCtD
Penicillamine—Leukaemia—Epirubicin—bone cancer	0.0114	0.0213	CcSEcCtD
Penicillamine—Leukaemia—Doxorubicin—bone cancer	0.0106	0.0197	CcSEcCtD
Penicillamine—Optic neuritis—Cisplatin—bone cancer	0.00973	0.0182	CcSEcCtD
Penicillamine—Pulmonary fibrosis—Methotrexate—bone cancer	0.00747	0.0139	CcSEcCtD
Penicillamine—Ageusia—Cisplatin—bone cancer	0.00739	0.0138	CcSEcCtD
Penicillamine—Extravasation—Cisplatin—bone cancer	0.00686	0.0128	CcSEcCtD
Penicillamine—Interstitial pneumonia—Methotrexate—bone cancer	0.0068	0.0127	CcSEcCtD
Penicillamine—Appetite absent—Methotrexate—bone cancer	0.0066	0.0123	CcSEcCtD
Penicillamine—Body temperature increased—Carboplatin—bone cancer	0.00576	0.0107	CcSEcCtD
Penicillamine—Neuropathy—Cisplatin—bone cancer	0.00562	0.0105	CcSEcCtD
Penicillamine—Eruption—Methotrexate—bone cancer	0.00534	0.00997	CcSEcCtD
Penicillamine—Eruption—Epirubicin—bone cancer	0.005	0.00933	CcSEcCtD
Penicillamine—Optic neuritis—Epirubicin—bone cancer	0.005	0.00933	CcSEcCtD
Penicillamine—Thrombocytosis—Epirubicin—bone cancer	0.00494	0.00923	CcSEcCtD
Penicillamine—Bone marrow depression—Methotrexate—bone cancer	0.00487	0.00908	CcSEcCtD
Penicillamine—Haemolytic anaemia—Cisplatin—bone cancer	0.00481	0.00899	CcSEcCtD
Penicillamine—Interstitial lung disease—Methotrexate—bone cancer	0.00464	0.00866	CcSEcCtD
Penicillamine—Optic neuritis—Doxorubicin—bone cancer	0.00462	0.00863	CcSEcCtD
Penicillamine—Eruption—Doxorubicin—bone cancer	0.00462	0.00863	CcSEcCtD
Penicillamine—Thrombocytosis—Doxorubicin—bone cancer	0.00457	0.00854	CcSEcCtD
Penicillamine—Bone marrow depression—Epirubicin—bone cancer	0.00455	0.0085	CcSEcCtD
Penicillamine—Bone marrow depression—Doxorubicin—bone cancer	0.00421	0.00787	CcSEcCtD
Penicillamine—Rash erythematous—Epirubicin—bone cancer	0.00401	0.00749	CcSEcCtD
Penicillamine—Ageusia—Epirubicin—bone cancer	0.00379	0.00708	CcSEcCtD
Penicillamine—Extravasation—Methotrexate—bone cancer	0.00376	0.00703	CcSEcCtD
Penicillamine—Proteinuria—Methotrexate—bone cancer	0.00374	0.00698	CcSEcCtD
Penicillamine—Rash erythematous—Doxorubicin—bone cancer	0.00371	0.00693	CcSEcCtD
Penicillamine—Protein urine present—Methotrexate—bone cancer	0.00369	0.00688	CcSEcCtD
Penicillamine—Pancreatitis—Cisplatin—bone cancer	0.00368	0.00687	CcSEcCtD
Penicillamine—Pancytopenia—Cisplatin—bone cancer	0.00357	0.00666	CcSEcCtD
Penicillamine—Glossitis—Methotrexate—bone cancer	0.00356	0.00665	CcSEcCtD
Penicillamine—Extravasation—Epirubicin—bone cancer	0.00352	0.00658	CcSEcCtD
Penicillamine—Ageusia—Doxorubicin—bone cancer	0.00351	0.00655	CcSEcCtD
Penicillamine—Vasculitis—Methotrexate—bone cancer	0.00337	0.00628	CcSEcCtD
Penicillamine—Glossitis—Epirubicin—bone cancer	0.00334	0.00623	CcSEcCtD
Penicillamine—Renal failure—Cisplatin—bone cancer	0.00329	0.00615	CcSEcCtD
Penicillamine—Neuropathy peripheral—Cisplatin—bone cancer	0.00328	0.00613	CcSEcCtD
Penicillamine—Stomatitis—Cisplatin—bone cancer	0.00326	0.00609	CcSEcCtD
Penicillamine—Extravasation—Doxorubicin—bone cancer	0.00326	0.00609	CcSEcCtD
Penicillamine—Hepatobiliary disease—Cisplatin—bone cancer	0.00317	0.00591	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—bone cancer	0.00309	0.00576	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—bone cancer	0.00308	0.00576	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—bone cancer	0.00297	0.00554	CcSEcCtD
Penicillamine—Urinary tract disorder—Cisplatin—bone cancer	0.00297	0.00554	CcSEcCtD
Penicillamine—Urethral disorder—Cisplatin—bone cancer	0.00295	0.0055	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—bone cancer	0.00289	0.00539	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—bone cancer	0.00289	0.00539	CcSEcCtD
Penicillamine—Tinnitus—Cisplatin—bone cancer	0.0028	0.00523	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—bone cancer	0.00279	0.00522	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—bone cancer	0.00278	0.00519	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—bone cancer	0.00275	0.00514	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—bone cancer	0.00267	0.00499	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—bone cancer	0.00267	0.00499	CcSEcCtD
Penicillamine—Alopecia—Cisplatin—bone cancer	0.00266	0.00496	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—bone cancer	0.00265	0.00495	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—bone cancer	0.00262	0.00488	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—bone cancer	0.00258	0.00481	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—bone cancer	0.00257	0.0048	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—bone cancer	0.00257	0.00479	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—bone cancer	0.00255	0.00477	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—bone cancer	0.00253	0.00472	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—bone cancer	0.00248	0.00464	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—bone cancer	0.00242	0.00452	CcSEcCtD
Penicillamine—Anaemia—Cisplatin—bone cancer	0.00242	0.00452	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—bone cancer	0.00239	0.00445	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.00237	0.00443	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—bone cancer	0.00236	0.00442	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—bone cancer	0.00236	0.00441	CcSEcCtD
Penicillamine—Leukopenia—Cisplatin—bone cancer	0.00234	0.00437	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—bone cancer	0.0023	0.00429	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—bone cancer	0.00229	0.00427	CcSEcCtD
Penicillamine—Anxiety—Cisplatin—bone cancer	0.00222	0.00414	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00221	0.00413	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00219	0.00409	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00215	0.00401	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—bone cancer	0.00212	0.00395	CcSEcCtD
Penicillamine—Thrombocytopenia—Cisplatin—bone cancer	0.00209	0.0039	CcSEcCtD
Penicillamine—Skin disorder—Cisplatin—bone cancer	0.00207	0.00387	CcSEcCtD
Penicillamine—Asthma—Methotrexate—bone cancer	0.00206	0.00385	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—bone cancer	0.00204	0.00381	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—bone cancer	0.00204	0.00381	CcSEcCtD
Penicillamine—Anorexia—Cisplatin—bone cancer	0.00204	0.0038	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—bone cancer	0.00202	0.00377	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00201	0.00375	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—bone cancer	0.00197	0.00367	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—bone cancer	0.00196	0.00365	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00195	0.00363	CcSEcCtD
Penicillamine—Asthma—Epirubicin—bone cancer	0.00193	0.0036	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—bone cancer	0.00191	0.00357	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—bone cancer	0.00189	0.00353	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—bone cancer	0.00189	0.00352	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00186	0.00347	CcSEcCtD
Penicillamine—Decreased appetite—Cisplatin—bone cancer	0.00186	0.00347	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—bone cancer	0.00183	0.00342	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—bone cancer	0.00182	0.0034	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—bone cancer	0.00181	0.00337	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—bone cancer	0.00179	0.00334	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—bone cancer	0.00178	0.00333	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—bone cancer	0.00177	0.0033	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—bone cancer	0.00175	0.00327	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—bone cancer	0.00175	0.00327	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—bone cancer	0.00174	0.00324	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—bone cancer	0.00171	0.0032	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—bone cancer	0.00169	0.00316	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—bone cancer	0.00169	0.00316	CcSEcCtD
Penicillamine—Body temperature increased—Cisplatin—bone cancer	0.00169	0.00315	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—bone cancer	0.00169	0.00315	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—bone cancer	0.00168	0.00313	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—bone cancer	0.00166	0.0031	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—bone cancer	0.00165	0.00308	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—bone cancer	0.00164	0.00306	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—bone cancer	0.00163	0.00304	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—bone cancer	0.00163	0.00304	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—bone cancer	0.00162	0.00302	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—bone cancer	0.0016	0.003	CcSEcCtD
Penicillamine—Hypersensitivity—Cisplatin—bone cancer	0.00157	0.00294	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—bone cancer	0.00156	0.00292	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00156	0.00291	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—bone cancer	0.00155	0.0029	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—bone cancer	0.00155	0.0029	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—bone cancer	0.00154	0.00288	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—bone cancer	0.00154	0.00287	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—bone cancer	0.00152	0.00285	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—bone cancer	0.00152	0.00283	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—bone cancer	0.00151	0.00283	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—bone cancer	0.0015	0.00281	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—bone cancer	0.0015	0.00279	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—bone cancer	0.00148	0.00277	CcSEcCtD
Penicillamine—Diarrhoea—Cisplatin—bone cancer	0.00146	0.00273	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—bone cancer	0.00146	0.00272	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—bone cancer	0.00145	0.0027	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—bone cancer	0.00144	0.00269	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—bone cancer	0.00144	0.00268	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—bone cancer	0.00143	0.00267	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—bone cancer	0.00141	0.00263	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—bone cancer	0.00141	0.00263	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—bone cancer	0.0014	0.00261	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—bone cancer	0.0014	0.00261	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—bone cancer	0.00136	0.00255	CcSEcCtD
Penicillamine—Vomiting—Cisplatin—bone cancer	0.00136	0.00254	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—bone cancer	0.00135	0.00252	CcSEcCtD
Penicillamine—Rash—Cisplatin—bone cancer	0.00135	0.00251	CcSEcCtD
Penicillamine—Dermatitis—Cisplatin—bone cancer	0.00135	0.00251	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—bone cancer	0.00133	0.00249	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—bone cancer	0.00133	0.00248	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—bone cancer	0.00132	0.00246	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—bone cancer	0.0013	0.00242	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—bone cancer	0.00129	0.0024	CcSEcCtD
Penicillamine—Nausea—Cisplatin—bone cancer	0.00127	0.00237	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—bone cancer	0.00126	0.00236	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—bone cancer	0.00125	0.00234	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—bone cancer	0.00124	0.00232	CcSEcCtD
Penicillamine—Agitation—Epirubicin—bone cancer	0.00123	0.00231	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—bone cancer	0.00122	0.00228	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—bone cancer	0.00122	0.00227	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00121	0.00227	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—bone cancer	0.0012	0.00225	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—bone cancer	0.00115	0.00215	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—bone cancer	0.00115	0.00214	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—bone cancer	0.00114	0.00214	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—bone cancer	0.00114	0.00213	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—bone cancer	0.00114	0.00213	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—bone cancer	0.00114	0.00213	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00114	0.00212	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—bone cancer	0.00112	0.00209	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—bone cancer	0.00111	0.00208	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—bone cancer	0.00107	0.002	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00107	0.00199	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—bone cancer	0.00107	0.00199	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—bone cancer	0.00106	0.00198	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—bone cancer	0.00105	0.00197	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00105	0.00196	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—bone cancer	0.00105	0.00195	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—bone cancer	0.00102	0.0019	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000999	0.00187	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—bone cancer	0.000994	0.00186	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—bone cancer	0.000986	0.00184	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—bone cancer	0.000967	0.00181	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—bone cancer	0.000953	0.00178	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—bone cancer	0.000931	0.00174	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—bone cancer	0.000926	0.00173	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000925	0.00173	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—bone cancer	0.000882	0.00165	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—bone cancer	0.000871	0.00163	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—bone cancer	0.000867	0.00162	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—bone cancer	0.000863	0.00161	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—bone cancer	0.000808	0.00151	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—bone cancer	0.000806	0.00151	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—bone cancer	0.000802	0.0015	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—bone cancer	0.000802	0.0015	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—bone cancer	0.00075	0.0014	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—bone cancer	0.000748	0.0014	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—bone cancer	0.000745	0.00139	CcSEcCtD
Penicillamine—Rash—Methotrexate—bone cancer	0.000739	0.00138	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—bone cancer	0.000738	0.00138	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—bone cancer	0.000697	0.0013	CcSEcCtD
Penicillamine—Nausea—Methotrexate—bone cancer	0.000696	0.0013	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—bone cancer	0.000694	0.0013	CcSEcCtD
Penicillamine—Rash—Epirubicin—bone cancer	0.000692	0.00129	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—bone cancer	0.000691	0.00129	CcSEcCtD
Penicillamine—Nausea—Epirubicin—bone cancer	0.000651	0.00122	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—bone cancer	0.000645	0.0012	CcSEcCtD
Penicillamine—Rash—Doxorubicin—bone cancer	0.00064	0.00119	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—bone cancer	0.000639	0.00119	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—bone cancer	0.000603	0.00113	CcSEcCtD
